Allergy Therapeutics plc Announces Change In Shareholding
Allergy Therapeutics, the specialty pharmaceuticals company focused on allergy vaccines, has today (Wednesday) received notification from ING Bank NV ("ING") and Elan International Services Limited ("Elan") that they no longer have an interest in the Company's share capital.